National HealthCare Corporation
AMEX:NHCMedical - Care Facilities
+$1.33 today
- Market cap
- $3.16B
- Beta
- 0.67
- P/E (TTM)
- 24.2
- EPS (TTM)
- $7.96
- Dividend yield
- 1.33%
Volume 0.10M
Average 0.12M
NHC Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
National HealthCare CorporationAMEX: NHC
Net Change in Cash · Q3 FY2026 · quarter ended Sep 2026
Net change in cash growth accelerates
Q3 FY2026 net change in cash of $34.04M rose 60.8% year over year, ahead of the -278.8% change in trailing-twelve-month net change in cash.
Context
- Net change in cash amounted to 1.0% of revenue in FY2025, down 1.2 pp from a year earlier.
- Net change in cash increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +60.8% holds above the trailing-twelve-month pace of -278.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 15.27M USD
- Year-over-year change
- +152.6%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.27M | +152.6% |
| FY2024 | 2024-12-31 | (29.05M) | -156.8% |
| FY2023 | 2023-12-31 | 51.1M | +213.9% |
| FY2022 | 2022-12-31 | (44.88M) | -15.8% |
| FY2021 | 2021-12-31 | (38.76M) | — |
Net Change in Cash vs competitors
How NHC compares with its peers on the latest reported figures
- NHC's LTM Sep 2026 net change in cash of $65.18M is the 5th largest of the 10 companies compared; the peer median is $8.39M.
- Its year-over-year change of -278.8% is the 9th highest of 10, against a peer median of -10.3%.
- Net change in cash amounts to 4.1% of revenue for NHC, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $209.68M | -876.6% | — | 8.1% | |
| LTM Jun 2026 | $101.67M | -10.3% | -10.1% | 1.9% | |
| LTM Mar 2026 | $67.81M | +1392.5% | -47.8% | 16.5% | |
| LTM Sep 2026 | $65.22M | +1990.3% | — | 2.2% | |
| LTM Sep 2026 | $65.18M | -278.8% | — | 4.1% | |
| LTM Oct 2026 | $51.98M | -22.9% | — | 1.9% | |
| LTM Mar 2026 | $38.47M | +505.1% | — | 4.1% | |
| LTM Jun 2026 | $8.39M | +110.2% | -42.1% | 0.6% | |
| LTM Jun 2026 | $3.9M | -91.3% | -32.9% | 0.1% | |
| LTM Mar 2026 | $309K | -112.4% | +32.4% | 0.0% | |
| Peer median (excluding NHC) | $8.39M | -10.3% | -32.9% | 1.9% | |
Competitors are the stored peer set for NHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 139.09M | 19.98M | 65.29M | 102.09M | 122.61M |
| Depreciation & Amortization | 40.67M | 40.49M | 42.03M | 41.99M | 44.92M |
| Deferred Income Tax | (6.29M) | 6M | 5.77M | 17.94M | 6.48M |
| Stock-Based Compensation | 2.62M | 2.61M | 2.78M | 4.16M | 4.4M |
| Change in Working Capital | (40.74M) | (73.7M) | 17.4M | (25.72M) | 33.4M |
| Accounts Receivables | 4.09M | (3.86M) | (8.56M) | (26.44M) | (3.68M) |
| Inventory | 199K | 1.49M | (298K) | (599K) | 1.24M |
| Accounts Payables | (2.08M) | (5.53M) | 2.24M | 6.3M | (2.73M) |
| Other Working Capital | (42.94M) | (65.8M) | 24.02M | (4.98M) | 38.55M |
| Other Non-Cash Items | (72.95M) | 13.37M | (22.05M) | (33.15M) | (26.72M) |
| Operating Cash Flow | 62.39M | 8.74M | 111.22M | 107.3M | 185.08M |
| Capital Expenditures | (39.4M) | (30.2M) | (27.9M) | (27.6M) | (36.45M) |
| Acquisitions (Net) | (29.06M) | 0 | (7.36M) | (228.1M) | (5.63M) |
| Purchases of Investments | (108.19M) | (33.79M) | (29.5M) | (35.06M) | (65.19M) |
| Sales of Investments | 101.92M | 49.96M | 47.4M | 51.97M | 72.89M |
| Other Investing Activities | 8.84M | 8.05M | (201K) | 2.09M | 512K |
| Investing Cash Flow | (65.89M) | (5.98M) | (17.57M) | (236.69M) | (33.86M) |
| Debt Repayment | (4.42M) | (4.7M) | (4.99M) | 136.14M | (97M) |
| Common Stock Issued | 3.44M | 2.11M | 313K | 14.27M | 14.21M |
| Common Stock Repurchased | (836K) | (9.9M) | (2.48M) | (13.5M) | (14.73M) |
| Dividends Paid | (32.03M) | (34.6M) | (35.56M) | (36.96M) | (38.7M) |
| Other Financing Activities | (1.42M) | (554K) | 169K | 402K | 265K |
| Financing Cash Flow | (35.26M) | (47.64M) | (42.55M) | 100.34M | (135.96M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (38.76M) | (44.88M) | 51.1M | (29.05M) | 15.27M |
| Free Cash Flow | 23M | (21.46M) | 83.32M | 79.7M | 148.63M |
National HealthCare Corporation
AMEX:NHC
Intrinsic Alpha fair value
Locked
Current Price
$201.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.